BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30611663)

  • 1. mRNA-Based Protein Replacement Therapy for the Heart.
    Magadum A; Kaur K; Zangi L
    Mol Ther; 2019 Apr; 27(4):785-793. PubMed ID: 30611663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Application of Modified mRNA in Cardiac Regeneration.
    Wang AYL; Chang YC; Chen KH; Loh CYY
    Cell Transplant; 2024; 33():9636897241248956. PubMed ID: 38715279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified mRNA as a Treatment for Myocardial Infarction.
    Wang Y; Wu M; Guo H
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct reprogramming induces vascular regeneration post muscle ischemic injury.
    Kaur K; Hadas Y; Kurian AA; Żak MM; Yoo J; Mahmood A; Girard H; Komargodski R; Io T; Santini MP; Sultana N; Sharkar MTK; Magadum A; Fargnoli A; Yoon S; Chepurko E; Chepurko V; Eliyahu E; Pinto D; Lebeche D; Kovacic JC; Hajjar RJ; Rafii S; Zangi L
    Mol Ther; 2021 Oct; 29(10):3042-3058. PubMed ID: 34332145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.
    Sultana N; Sharkar MTK; Hadas Y; Chepurko E; Zangi L
    Methods Mol Biol; 2021; 2158():281-294. PubMed ID: 32857381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.
    Huang CL; Leblond AL; Turner EC; Kumar AH; Martin K; Whelan D; O'Sullivan DM; Caplice NM
    Mol Pharm; 2015 Mar; 12(3):991-6. PubMed ID: 25588055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified mRNA as a Therapeutic Tool for the Heart.
    Kaur K; Zangi L
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):871-880. PubMed ID: 32822006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs in endothelial cell signalling and hypoxia during cardiac regeneration.
    Peters MMC; Sampaio-Pinto V; da Costa Martins PA
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118515. PubMed ID: 31362011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease.
    Hadas Y; Katz MG; Bridges CR; Zangi L
    Wiley Interdiscip Rev Syst Biol Med; 2017 Jan; 9(1):. PubMed ID: 27911047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Modified mRNA in a Myocardial Infarction Mouse Model.
    Kaur K; Sultana N; Hadas Y; Magadum A; Sharkar MTK; Chepurko E; Zangi L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified mRNA Therapeutics for Heart Diseases.
    Magadum A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Synthesis of Modified mRNA.
    Yoo J; Zangi L
    Methods Mol Biol; 2022; 2573():77-87. PubMed ID: 36040588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration.
    Labonia MCI; Estapé Senti M; van der Kraak PH; Brans MAD; Dokter I; Streef TJ; Smits AM; Deshantri AK; de Jager SCA; Schiffelers RM; Sluijter JPG; Vader P
    J Control Release; 2024 May; 369():734-745. PubMed ID: 38604385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction.
    Lesizza P; Prosdocimo G; Martinelli V; Sinagra G; Zacchigna S; Giacca M
    Circ Res; 2017 Apr; 120(8):1298-1304. PubMed ID: 28077443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Cardiac Delivery of Modified mRNA.
    Sultana N; Magadum A; Hadas Y; Kondrat J; Singh N; Youssef E; Calderon D; Chepurko E; Dubois N; Hajjar RJ; Zangi L
    Mol Ther; 2017 Jun; 25(6):1306-1315. PubMed ID: 28389322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms Underlying Cardiomyocyte Development: Can We Exploit Them to Regenerate the Heart?
    Maldonado-Velez G; Firulli AB
    Curr Cardiol Rep; 2021 Jun; 23(7):81. PubMed ID: 34081213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.
    Xiang FL; Guo M; Yutzey KE
    Circulation; 2016 Mar; 133(11):1081-92. PubMed ID: 26841808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large Animal Models of Cell-Free Cardiac Regeneration.
    Spannbauer A; Mester-Tonczar J; Traxler D; Kastner N; Zlabinger K; Hašimbegović E; Riesenhuber M; Pavo N; Goliasch G; Gyöngyösi M
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33003617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].
    Centola M; Schuleri KH; Lardo AC; Hare JM
    G Ital Cardiol (Rome); 2008 Apr; 9(4):234-50. PubMed ID: 18543793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac regeneration: the gene therapy approach.
    Laguens RP; Crottogini AJ
    Expert Opin Biol Ther; 2009 Apr; 9(4):411-25. PubMed ID: 19344279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.